Showing results (191-200 of 271) with videos related to

Sort By:
Pageof 28
BMC Geriatrics|September 19, 2018
Adherence to driving cessation advice given to patients with cognitive impairment and consequences for mobilityDafne Piersma, Anselm B M Fuermaier, Dick De Waard, et al.
BMC Molecular and Cell Biology|November 13, 2020
Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrilsAndré Marreiro, Kristof Van Kolen, Cristiano Sousa, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2012
Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's diseasePetrus J W Naudé, Csaba Nyakas, Lee E Eiden, et al.
Neurobiology of Aging|January 15, 2013
Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patientsLubina Dillen, Tim Van Langenhove, Sebastiaan Engelborghs, et al.
Neurobiology of Disease|June 19, 2017
Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse modelsAlain D Dekker, Yannick Vermeiren, Christelle Albac, et al.
Alzheimer'S Research & Therapy|September 12, 2020
Amyloid-β<sub>1-43</sub> cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutationsFederica Perrone, Maria Bjerke, Elisabeth Hens, et al.
Molecular Psychiatry|July 11, 2023
Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protectionRita Cacace, Lujia Zhou, Elisabeth Hendrickx Van de Craen, et al.
The Lancet. Neurology|July 5, 2015
Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing studyElise Cuyvers, Arne De Roeck, Tobi Van den Bossche, et al.
Frontiers in Molecular Neuroscience|July 18, 2017
Increased White Matter Inflammation in Aging- and Alzheimer's Disease BrainDivya Raj, Zhuoran Yin, Marjolein Breur, et al.
Neurobiology of Aging|August 8, 2021
Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementiaPetrus J W Naudé, Inez H G B Ramakers, Wiesje M van der Flier, et al.
Pageof 28